Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
815.40
Change Change %
28.15 3.58%

Updated:25 May, 2018, 10:34 AM IST

BSE
813.65
Change Change %
27.00 3.43%

Updated:25 May, 2018, 10:31 AM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

790.00 816.70

52 Wk Range

600.00 1039.00
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

790.00815.95

52 Wk Range

600.00 1039.00
 

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Motilal Oswal
-
09-01-2018 Buy 791.25 957.00 Target Hit Details
Nomura
-
20-07-2017 Buy 736.05 855.00 Target Hit Details
Macquarie
-
24-05-2017 Buy 749.70 1000.00 Target Hit Details
Macquarie
-
05-01-2017 Buy 749.80 - Closed Details
Macquarie
-
04-10-2016 Buy 648.45 725.00 Target Hit Details

More from Research Reports »

Jubilant LifeScience's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 12,987.77
Earning Per Share (EPS TTM) (₹) 16.54
Price To Earnings (P/E) Ratio 49.30
Book Value Per Share (₹) 128.25
Price To Books (P/B) Ratio 6.36
EBIT Margin (%) 11.01
PAT Margin (%) 3.02
ROCE (%) 7.64
PAT Growth (%) 8.48
Total Debt to Equity (D/E) Ratio 0.83

More from Key Fundamentals »

Jubilant LifeScience's Financial Summary

Parameter MAR'17
(₹ Cr.)
MAR'16
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 15.93 15.93 0.00%
Total Non-Current Liabilities 1,428.31 1,136.80 25.64%
Total Current Liabilities 910.68 1,155.23 -21.17%
Total Liabilities 4,381.79 4,305.76 1.77%
Total Non-Current Assets 3,237.48 3,238.16 -0.02%
Currents Investments 9.70 7.35 31.97%
Cash and Bank 76.66 41.05 86.75%
Total Current Assets Excluding Current Investments 1,134.61 1,060.25 7.01%
Total Assets 4,381.79 4,305.76 1.77%
Profit and Loss:
Gross Sales 2,622.99 2,790.95 -6.02%
Net Sales 2,491.22 2,656.15 -6.21%
PBIDT (Excl OI) 318.01 312.29 1.83%
PAT 79.19 73.00 8.48%

More from Financial Summary »

Jubilant LifeScience's Shareholding Pattern

..

Post your comments about Jubilant LifeScience

Top